Please login to the form below

Not currently logged in
Email:
Password:

TEVA-48125

This page shows the latest TEVA-48125 news and features for those working in and with pharma, biotech and healthcare.

Teva says chronic migraine drug is ready for phase III

Teva says chronic migraine drug is ready for phase III

TEV-48125 efficacy “has not previously been achieved”.  . Teva's novel migraine drug TEV-48125 should start phase III trials shortly, after showing 'unprecedented' activity in a mid-stage study, says ... year. The efficacy shown by TEV-48125 "has

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
...
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics